The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study
Eberhard Grube1*, MD; Donald Baim2, MD; Daniel Burkhoff3, MD; Ralf Mueller1, MD; Lutz Buellesfeld1, MD; Paul Teirstein4#, MD
1. Heart Center Siegburg, Germany; 2. Brigham & Women’s Hospital, Boston, MA, USA; 3. Columbia Presbyterian, New York; NY, USA; 4. Scripps Clinic, La Jolla, CA, USA
Aim: Typical intravenous fenoldopam doses result in only minimal increases in renal blood flow and glomerular filtration, while higher doses are associated with systemic hypotension. We hypothesized that local in